Search
for
Sort by
Research 30 of 474
- Treatment of alopecia areata: “What is new on the horizon?”
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata
- Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda minima
- iNKT cells ameliorate human autoimmunity: Lessons from alopecia areata
- Resident human dermal γδT-cells operate as stress-sentinels: Lessons from the hair follicle
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- Aberrant Activation of the Hedgehog Pathway in Cutaneous Melanoma: Therapeutic Potential of Pharmacological Inhibitors
- Natural Killer Group 2 Type D (NKG2D) Gene Polymorphism in Systemic Lupus Erythematosus-Suez Canal Region - Egypt
- Dietary vitamin A regulates wingless-related MMTV integration site signaling to alter the hair cycle
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- Alopecia Areata
- Lichen Planopilaris and Frontal Fibrosing Alopecia as Model Epithelial Stem Cell Diseases
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
- Multimodal roles of transient receptor potential channel activation in inducing pathological tissue scarification
- γδ17 T cell-stromal networks modulate matrix composition and vascularity in foreign body response
- Meta-Analysis of Gene Expression Reveals the Core Transcriptomic Profile of Lesional Scalp in Alopecia Areata
- Performance exploration of multi-gene panels of alopecia areata susceptibility and drug-binding targets
- Mechanisms regulating skin immunity and inflammation
- The Dynamics of the Skin’s Immune System
- Langerin+ Dendritic Cells in Cutaneous Fibrosis: The TGF-β1 Signaling Axis
- Differential impact of environmental factors on systemic and localized autoimmunity
- Pathophysiology of Alopecia Areata in the Pediatric Patient
- Targeting integrin pathways: mechanisms and advances in therapy
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- Editor's evaluation: Involvement of ILC1-like innate lymphocytes in human autoimmunity, lessons from alopecia areata